Herpes zoster oticus (HZO) is one of the clinical syndromes which develops after the initial colonization of varicella virus in the ganglia of the cranial nerves [1] [2]. Defined as an infection of the ear that appears after reactivation of VZV from the geniculate ganglion, this clinical entity is now a rare occurrence in clinical practice, and is predominantly encountered among elderly individuals [1] [3] [4]. The clinical presentation comprises of a typical rash in the form of erupting vesicles in the external auditory canal, the eardrum, pinna, and cavum conchae, whereas otalgia (ear pain that is described as severe), tinnitus, vertigo, and even hearing impairment are reported [1] [2] [4] [5] [6]. Higher frequencies are more severely affected than lower frequencies, and in a number of patients, hearing loss can be severe enough to result in deafness [4] [5]. Paresis of the facial nerve on the ipsilateral side (manifesting as unilateral facial paralysis and asymmetry of the face) quite often accompanies the typical features of herpes zoster oticus and the term Ramsay Hunt syndrome (named after the first physician who described the condition) is used for this condition in the literature [2] [5] [6]. Other notable symptoms are nausea, vomiting, nystagmus, and distribution of lesions in the oral cavity, while pain may spread throughout the face and neck area [1] [2].

With a thorough clinical workup, herpes zoster oticus can be easily diagnosed. Firstly, a detailed patient history should assess the presenting complaints, their duration, as well as severity, but the role of a properly conducted physical examination is perhaps of essential importance. A full inspection of the auditory canal and the face is sufficient to identify vesicular rash that is highly suggestive of a VZV infection. Furthermore, if facial paralysis is suspected, a neurological examination including the assessment of cranial nerves will detect features of facial nerve palsy [2]. Weakness of the muscles of facial expression supplied by the facial nerve will manifest as a drooping lower lid, incomplete eye closure, reduced movement of the lip and the forehead, and facial asymmetry [2]. Thus, a combination of clinical findings is usually enough to make the diagnosis of herpes zoster oticus or Ramsay Hunt syndrome, but in some patients, the findings may be nonspecific and microbiological studies should be performed in those cases. Detection of high antibody titers is a useful initial method, but testing of samples obtained from swabs or ear fluid by polymerase chain reaction (PCR) is a highly recommended diagnostic tool that carries a high rate of success [1] [6] [7].

The primary treatment for Herpes Zoster Oticus involves antiviral medications, such as acyclovir, valacyclovir, or famciclovir, which are most effective when started within 72 hours of symptom onset. Corticosteroids, like prednisone, may be prescribed to reduce inflammation and swelling. Pain management is crucial and may involve analgesics or nerve pain medications. In some cases, physical therapy may be recommended to help regain facial muscle function.

The prognosis for Herpes Zoster Oticus varies. Early treatment can improve outcomes, but some patients may experience long-term complications, such as persistent facial weakness, hearing loss, or postherpetic neuralgia (chronic pain in the area of the rash). Recovery can take weeks to months, and some symptoms may never fully resolve. Regular follow-up with healthcare providers is essential to monitor progress and manage any ongoing issues.

Herpes Zoster Oticus is caused by the reactivation of the varicella-zoster virus, which remains dormant in the body after an initial chickenpox infection. Factors that can trigger reactivation include stress, a weakened immune system, or aging. Once reactivated, the virus travels along nerve pathways, leading to the characteristic symptoms of the condition.

Herpes Zoster Oticus is relatively rare, accounting for a small percentage of all shingles cases. It can occur at any age but is more common in older adults and those with weakened immune systems. The incidence is not significantly influenced by gender or ethnicity. Awareness of the condition is crucial for early diagnosis and treatment.

The pathophysiology of Herpes Zoster Oticus involves the reactivation of the varicella-zoster virus in the geniculate ganglion, a collection of nerve cells associated with the facial nerve. This reactivation leads to inflammation and damage to the facial nerve, resulting in the symptoms of facial paralysis and rash. The virus can also affect other cranial nerves, leading to additional symptoms like hearing loss and vertigo.

Preventing Herpes Zoster Oticus primarily involves vaccination. The shingles vaccine is recommended for older adults and those at higher risk of reactivation. Maintaining a healthy immune system through a balanced diet, regular exercise, and stress management can also help reduce the risk. Early treatment of shingles can prevent complications like Herpes Zoster Oticus.

Herpes Zoster Oticus is a rare but serious complication of shingles, characterized by a painful rash and facial paralysis. Early diagnosis and treatment with antivirals and corticosteroids are crucial for improving outcomes. While the prognosis varies, some patients may experience long-term effects. Prevention through vaccination and maintaining a healthy lifestyle is key to reducing the risk of this condition.

If you suspect you have Herpes Zoster Oticus, it's important to seek medical attention promptly. Look out for symptoms like a painful rash on or around the ear, facial weakness, and hearing changes. Early treatment can help manage symptoms and improve recovery. Remember, vaccination is an effective way to prevent shingles and its complications. Stay informed and proactive about your health to minimize risks.

1. Gondivkar S, Parikh V, Parikh R. Herpes zoster oticus: A rare clinical entity. Contemp Clin Dent. 2010;1(2):127-129.
2. Wagner G, Klinge H, Sachse MM. Ramsay Hunt syndrome. J Dtsch Dermatol Ges. 2012;10(4):238-244.
3. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82(11):1341-1349.
4. Sampathkumar P, Drage LA, Martin DP. Herpes Zoster (Shingles) and Postherpetic Neuralgia. Mayo Clin Proc. 2009;84(3):274-280.
5. Kim CH, Choi H, Shin JE. Characteristics of hearing loss in patients with herpes zoster oticus. Lin. Y-S, ed. Medicine (Baltimore). 2016;95(46):e5438.
6. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Neurological Disease Produced by Varicella Zoster Virus Reactivation Without Rash. Curr Top Microbiol Immunol. 2010;342:243-253.
7. Espy MJ, Teo R, Ross TK, et al. Diagnosis of Varicella-Zoster Virus Infections in the Clinical Laboratory by LightCycler PCR. J Clin Microbiol. 2000;38(9):3187-3189.